Literature DB >> 28012596

Breath Alkane as an index of severity for oral submucous fibrosis: A new perspective?

Gururaj Arakeri1, George Boraks2, Abdulsalam S Aljabab3, Shekar Gowda Patil4, M A W Merkx5, Peter A Brennan6.   

Abstract

Oral submucous fibrosis (OSMF) is a devastating disease commonly seen in the Asian subcontinent that results in significant functional morbidity for patients and has a high potential for malignant transformation. Over the last three decades, different diagnostic methods have been described to quantify and grade OSMF severity. Some methods have been used with perceived favorable outcomes although recurrence and malignant transformation remains a problem in many cases, and OSMF presents a major therapeutic challenge. We present a simple, noninvasive and less time-consuming diagnostic method which measures the severity of OSMF, helping to predict its malignant transformation and monitoring the effect of medical therapy on this disease.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breath Alkane; Diagnosis; Oral submucous fibrosis; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 28012596     DOI: 10.1016/j.mehy.2016.11.005

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  1 in total

1.  CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.

Authors:  L-C Silva; F-P Fonseca; O-P Almeida; B-A Mariz; M-A Lopes; R Radhakrishnan; M Sharma; L-P Kowalski; P-A Vargas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.